Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.85%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information
Ticker
SAGECompany Name
SAGE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSAGE THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SAGE - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 600K | 0.85% | $ 70.41M |
| 3/31/2025 | $ 807K | 1.7% | $ 47.4M |
| 12/31/2024 | $ 1.03M | 2.5% | $ 41.24M |
| 9/30/2024 | $ 1.31M | 1.23% | $ 106.4M |
| 6/30/2024 | $ 1.39M | 1.43% | $ 97.24M |
| 3/31/2024 | $ 1.41M | 1.54% | $ 91.06M |
| 12/31/2023 | $ 1.39M | 1.61% | $ 86.45M |
| 9/30/2023 | $ 1.27M | 11.23% | $ 11.35M |
| 6/30/2023 | $ 1.22M | 11.78% | $ 10.37M |
| 3/31/2023 | $ 1.17M | 12.45% | $ 9.4M |
Key Performance Insights, Last 5 Years
- SAGE THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 37.94%.
- Over the past 5 years, SAGE THERAPEUTICS INC's average DepAmor % has been 11.74%.
- The median DepAmor % for SAGE THERAPEUTICS INC during this period was 2.1%
- SAGE THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 66.3%.
- The lowest DepAmor % recorded by SAGE THERAPEUTICS INC in the same timeframe 0.24%
SAGE THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for SAGE THERAPEUTICS INC is calculated as follows: DepAmor [ $ 2.65M ] / Revenues [ $ 6.97M ]
(=) DepAmor % [ 37.94% ] SAGE - Depreciation and Amortization Margin, Last 5 years
0.24%
Minimum
Dec 31, 2020
66.3%
Maximum
Dec 31, 2021
11.74%
Average
2.1%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |